{"url_path":"/sec/rkda/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-223990-index.html","accession_number":"0001193125-26-223990","cik":"0001469443","ticker":"RKDA","issuer_name":"Arcadia Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-223990-index.html","primary_entity_key":"0001469443","primary_entity_name":"Arcadia Biosciences, Inc."},"word_count":46,"has_tables":true,"body_markdown":"ITEM 1. LEGAL PROCEEDINGS\n\n \n\nFrom time to time, we may be subject to legal proceedings and claims in the ordinary course of business. Please refer to Note 13 included in Part I, \"Item 1. Notes to Condensed Consolidated Financial Statements\" for a discussion of legal proceedings."}